BALYASNY ASSET MANAGEMENT L.P. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$124,887
+48.7%
29,594
+22.5%
0.00%
-100.0%
Q1 2020$84,000
-64.3%
24,151
-26.4%
0.00%
-50.0%
Q2 2019$235,000
-87.1%
32,834
-74.4%
0.00%
-83.3%
Q1 2019$1,815,000
+98.8%
128,121
+89.8%
0.01%
+71.4%
Q4 2018$913,000
-43.2%
67,516
-6.8%
0.01%0.0%
Q3 2018$1,608,00072,4740.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders